We are live on ! Find out more
FCMI

Foresite Capital Management IV Portfolio holdings

AUM $237M
1-Year Est. Return 107.53%
This Fund
S&P 500
This Quarter Est. Return
+12.45%
1 Year Est. Return
+107.53%
3 Year Est. Return
+149.4%
5 Year Est. Return
+13.8%
10 Year Est. Return
–
AUM
$143M
AUM Growth
–
Cap. Flow
+$129M
Cap. Flow %
90.44%
Top 10 Hldgs %
96.56%
Holding
13
New
13
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
INSM icon
Insmed
INSM
+$26M
2
CBAY
Cymabay Therapeutics
CBAY
+$19.3M
3
ASND icon
Ascendis Pharma A/S
ASND
+$19.2M
4
IMMU
Immunomedics Inc
IMMU
+$12.7M
5
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$11.9M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 87.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INSM icon
1
Insmed
INSM
$21.4B
$27.4M 19.23%
+879,910
New +$26M
ASND icon
2
Ascendis Pharma A/S
ASND
$16B
$21.2M 14.86%
+529,343
New +$19.2M
CBAY
3
DELISTED
Cymabay Therapeutics
CBAY
$20.7M 14.54%
+2,254,502
New +$19.3M
IMMU
4
DELISTED
Immunomedics Inc
IMMU
$17.3M 12.16%
+1,073,272
New +$12.7M
MYOK
5
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$13M 9.13%
+309,357
New +$11.9M
QURE icon
6
uniQure
QURE
$3.03B
$12.4M 8.72%
+635,234
New +$9.67M
OPTN
7
DELISTED
OptiNose
OPTN
$8.51M 5.96%
+30,000
New +$8.44M
ACRS icon
8
Aclaris Therapeutics
ACRS
$726M
$6.21M 4.36%
+251,936
New +$6.13M
BHVN
9
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$5.76M 4.04%
+213,435
New +$5.88M
RYTM icon
10
Rhythm Pharmaceuticals
RYTM
$6.81B
$5.09M 3.57%
+175,000
New +$4.63M
ALDR
11
DELISTED
Alder Biopharmaceuticals
ALDR
$2.67M 1.87%
+232,909
New +$2.6M
DNLI icon
12
Denali Therapeutics
DNLI
$3.65B
$1.48M 1.04%
+94,666
New +$1.7M
ABUS icon
13
Arbutus Biopharma
ABUS
$857M
$760K 0.53%
+150,592
New +$883K

Similar funds

BCM
Birmingham Capital Management Birmingham, Alabama $237M AUM 32.7% 1-Year Est. Return
AG
ASO Group Road Town $237M AUM
FL
FreeGulliver LLC New Orleans, Louisiana $237M AUM 21.92% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
MFA
Millington Financial Advisors Naperville, Illinois $237M AUM 22.22% 1-Year Est. Return
TCM
Tekne Capital Management New York $237M AUM 62.98% 1-Year Est. Return
WW
Windle Wealth Oklahoma City, Oklahoma $237M AUM 22.79% 1-Year Est. Return
CB
CNB Bank Clearfield, Pennsylvania $238M AUM 26.55% 1-Year Est. Return

Foresite Capital Management IV's Q4 2017 Portfolio in Review

Q4 2017 is the first quarter with a 13F filing on record for Foresite Capital Management IV, which disclosed 13 positions worth $143M. Its ten largest holdings account for 97% of the portfolio.

Its largest position is Insmed: 879,910 shares worth $27.4M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets.

  • Foresite Capital Management IV's largest Q4 2017 buy was Insmed: 879,910 shares worth $27.4M.
  • Foresite Capital Management IV's ten largest holdings make up 97% of its $143M portfolio in Q4 2017.
  • Foresite Capital Management IV disclosed 13 positions in Q4 2017, its first 13F filing on record.

Based on Foresite Capital Management IV's 13F filing for Q4 2017, filed 13 Feb 2018.